Trials / Unknown
UnknownNCT06041451
Early and Late Prognosis in Patients With Guillain-Barre Syndrome
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 450 (estimated)
- Sponsor
- First Affiliated Hospital of Wenzhou Medical University · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The goal of this observational study is to explore significant indicators to predict the early prognosis and late prognosis in patients with Guillain-Barre syndrome.
Detailed description
This is a multicenter study(approximately three) with over 450 subjects.Clinical data were collected by consulting the patient's electronic history. The data included demographic information, blood biochemical markers, clinical characteristics and electromyography. All participants provided their written informed consent to participate in this study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Intravenous Immunoglobulins, Human | patients were treated with intravenous immunoglobulin(30g ivgtt qd) for 5 days |
| DRUG | Methylprednisolone 500 MG Injection | patients were treated with methylprednisolone |
Timeline
- Start date
- 2013-01-02
- Primary completion
- 2022-12-01
- Completion
- 2025-01-31
- First posted
- 2023-09-18
- Last updated
- 2023-09-18
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06041451. Inclusion in this directory is not an endorsement.